Skip to main content
Clinical Trials/NCT01365273
NCT01365273CompletedPhase 4

Open, Prospective, Randomised Investigation Evaluating Pain With the Use of Mepitel One vs.Bridal Veil and Staples on Split Thickness Skin Grafts

Molnlycke Health Care AB4 sites in 1 country43 target enrollmentStarted: February 1, 2011Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Phase 4
Status
Completed
Sponsor
Enrollment
43
Locations
4
Primary Endpoint
VAS Score for Pain Before Dressing Removal

Study Overview

Brief Summary

This investigation is an open, randomised investigation. Approximately 40 subjects in 4-5 centres in the US with deep-partial of full thickness burns in need of skin grafts will be enrolled.The subjects will be equally randomised to either treatment with Mepitel One or bridal veil together with staples.

The primary objective is to compare pain at the time of dressing change for the use of Mepitel One versus bridal veil together with staples on deep partial or full thickness burns requiring skin grafts.

Detailed Description

Skin grafts are placed over excised areas of full thickness injuries and usually attached with sutures or staples. While useful in anchoring the graft in place, subjects often complain of pain from the staples as wound healing progresses.Pulling and sticking are common complaints.There is also a possibility that staples become embedded in the graft which leads to disruption of otherwise healed area, increased pain and anxiety for the subject as well as anxiety for the staff.

Graft take can be optimized with appropriate medical management. Use of non-adherent dressings to protect the graft is customary. Various types of netting-style are used, such as Bridal veil, a sterile product which is fixed over the graft with staples.

Silicone net dressings have also been used successfully to prevent lifting and adherence of skin grafts to the dressings, prevent pain and promote healing. Mepitel One is a sterile, transparent, and flexible wound contact layer consisting of perforated polyurethane film coated with Safetac soft silicone adhesive on one side. Mepitel One is available in various sizes and can be left in place for several days depending on the wound/skin condition.

Evaluation of burns will be performed at Baseline. Skin graft assessment will be performed at Day 7 and Day 14. End of study will be considered the time that graft is considered to have >95% take.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to 70 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Inclusion Criteria
  • •Subjects presenting with 1% - 25% Total Body Surface Area (TBSA) deep partial or full-thickness burns requiring skin graft
  • •At least 1%-10% TBSA is available for grafting that can be considered for study site selection (must have intact, healthy peri-wound area around entire portion of this burned site)
  • •Both genders with age ≥18 years but < 70 years
  • •Signed informed consent

Exclusion Criteria

  • •Subjects with chronic wounds
  • •Subjects who are on mechanical ventilation
  • •Subjects with dermatologic skin conditions or necrotizing disorders
  • •Diagnosed underlying disease(s) (HIV/AIDS, cancer and severe anaemia)judged by the investigator to be a potential interference in the treatment
  • •Subjects treated with systemic glucocorticosteroids, except subjects taking occasional doses or doses less than 10 mg prednisolon/day or equivalent
  • •Use of immunosuppressive agents, radiation or chemotherapy within the past 30 days
  • •Known allergy/hypersensitivity to any of the components of the investigational products
  • •Subjects with physical and/or mental conditions that are not expected to comply with the investigation
  • •Participation in other clinical investigation(s) within 1 month prior to start of the investigation
  • •Previously randomised to this investigation

Arms & Interventions

Bridal Veil together with staples

No Intervention

Standard of care. Bridal Veil is fixed over the graft with staples.

Mepitel One

Active Comparator

Device, dressing

Intervention: Mepitel One (Device)

Outcomes

Primary Outcomes

VAS Score for Pain Before Dressing Removal

Time Frame: At visit 6, day 7

Pain was measured with Visual Analogue Scale (VAS)(100 mm) measuring from 0 = "no pain" at one end to 100 = "most intense pain imagaginable" at the other end.

VAS Score for Pain During Dressing Removal

Time Frame: Visit 6, day 7

Pain when half of the study product(s) has been removed measued with Visual Analogue Scale (VAS).0 = "no pain" till 100 = "worst pain".

VAS Score for Pain After Dressing Removal

Time Frame: Visit 6, day 7

Pain after the dressing removal measued with Visual Analogue Scale (VAS).0 = "no pain" till 100 = "worst pain".

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Molnlycke Health Care AB
Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (4)

Loading locations...

Similar Trials